These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 7130336)

  • 41. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can citrate therapy prevent nephrolithiasis?
    Abdulhadi MH; Hall PM; Streem SB
    Urology; 1993 Mar; 41(3):221-4. PubMed ID: 8442301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some aspects of citrate metabolism in renal-stone patients from northeastern Thailand.
    Sriboonlue P; Prasongwatana V; Borvornpadoongkitti S; Suwantrai S
    J Med Assoc Thai; 1996 Nov; 79(11):737-43. PubMed ID: 8997014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on citrate metabolism in normal subjects and kidney stone patients.
    Minisola S; Rossi W; Pacitti MT; Scarnecchia L; Bigi F; Carnevale V; Mazzuoli G
    Miner Electrolyte Metab; 1989; 15(5):303-8. PubMed ID: 2811789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of hypocitraturia in kidney stone patients.
    Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary citrate excretion in idiopathic nephrolithiasis.
    Ratan SK; Bhatnagar V; Mitra DK; Basu N; Malhotra LK
    Indian Pediatr; 2002 Sep; 39(9):819-25. PubMed ID: 12368525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers.
    Houillier P; Normand M; Froissart M; Blanchard A; Jungers P; Paillard M
    Kidney Int; 1996 Sep; 50(3):987-97. PubMed ID: 8872975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
    Seltzer MA; Low RK; McDonald M; Shami GS; Stoller ML
    J Urol; 1996 Sep; 156(3):907-9. PubMed ID: 8709360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrolithiasis in renal tubular acidosis.
    Buckalew VM
    J Urol; 1989 Mar; 141(3 Pt 2):731-7. PubMed ID: 2645431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
    Preminger GM; Sakhaee K; Pak CY
    J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.